2013
DOI: 10.1016/j.biosystems.2013.05.007
|View full text |Cite
|
Sign up to set email alerts
|

The regulatory network that controls the differentiation of T lymphocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
23
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
3
3
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(24 citation statements)
references
References 68 publications
1
23
0
Order By: Relevance
“…According to what just said, it can be classified as a multiscale agent-based model. It consists in an agent-based formulation of the cell-cell/molecules interaction pertaining to hypersensitive responses to a generic allergen in which a detailed gene regulation dynamics is modeled by means of a Boolean network [55] (other approaches, as the use of a system of ordinary differential equations, would work as well [56]). The two levels (the intra- and the inter-cellular) are integrated in a quite intuitive way.…”
Section: Multiscale Methodsmentioning
confidence: 99%
“…According to what just said, it can be classified as a multiscale agent-based model. It consists in an agent-based formulation of the cell-cell/molecules interaction pertaining to hypersensitive responses to a generic allergen in which a detailed gene regulation dynamics is modeled by means of a Boolean network [55] (other approaches, as the use of a system of ordinary differential equations, would work as well [56]). The two levels (the intra- and the inter-cellular) are integrated in a quite intuitive way.…”
Section: Multiscale Methodsmentioning
confidence: 99%
“…In addition, a few studies have extended pre-existing networks to investigate specific interests. The main goals for developing Boolean networks have been to identify potential therapeutic strategies [106,17,18,107,25,26,2832,34], characterize cellular differentiation [14,11,13,36], understand differential responses to cancer therapies due to mutational differences [27], understand the impact of patient heterogeneity on the response to drug treatments [21,35], and as an initial framework prior to the development of quantitative models [23]. The networks provided in this table could be potentially extended or repurposed for investigating additional features of interest, as opposed to starting from the ground up.…”
Section: An Overview Of Boolean Network Applicationsmentioning
confidence: 99%
“…The state of each node is governed by the previous states of its regulating nodes through a set of logical functions. Boolean networks have been applied to model signal transduction, gene regulation, and cellular differentiation for several types of physiological and pathophysiological systems, such as the immune system and related diseases [1123], breast cancer [2429], gastrointestinal cancers [3032], hepatic cancer [33,34], lung cancer [35], and several others [3640]. In oncology, Boolean network modeling can provide a framework for studying system trajectories under pathophysiological conditions and in response to drug treatment.…”
Section: Introductionmentioning
confidence: 99%
“…10,11 The CD 41 T-lymphocytes could differentiate into several subsets such as Th1, Th2, and Treg etc., and they are involved in various immune responses. 12,13 Th1 is induced by IL-12 and IFN-g, secretes IFN-g and is involved in cell-mediated immune response; Th2 is induced by IL-4, secretes IL-4, IL-5, and IL-13 and is involved in the humoral immune response; studies have demonstrated that during immune response, IL-2, IL-4, IL-5, IL-6, etc. can promote T-lymphocytes activation, proliferation, and differentiation.…”
Section: Introductionmentioning
confidence: 99%